BCL-2 As a Potential Therapeutic Target in Human Lupus Tubulointerstitial Inflammation.

被引：0
|
作者：
Ko, Kichul [1 ]
Yanez, Denisse [1 ]
Kaverina, Natalya [1 ]
Liarski, Vladimir M. [1 ]
Peng, Yahui [2 ]
Lan, Li [1 ]
Perper, Stuart [3 ]
Schwartz, Annette [3 ]
O'connor, Liz [3 ]
Souers, Andrew [4 ]
Elmore, Steven [4 ]
Olson, Lisa [3 ]
Giger, Maryellen L. [1 ]
Wang, Li Chun [3 ]
Clark, Marcus R. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Beijing Jiaotong Univ, Beijing, Peoples R China
[3] AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
[4] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2839
引用
收藏
页码：S1241 / S1241
页数：1
相关论文
共 50 条
  • [41] Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
    Marcus R Clark
    Anthony Chang
    Kichul Ko
    Carole J Henry Dunand
    Scott Henderson
    Dan Brandt
    Natalya Kaverina
    Vladimir Liarski
    Patrick C Wilson
    Andrew J Kinloch
    Arthritis Research & Therapy, 16
  • [42] Bcl-2 expression in the human cornea
    Yamamoto, K
    Ladage, PM
    Ren, DH
    Li, L
    Petroll, WM
    Jester, JV
    Cavanagh, HD
    EXPERIMENTAL EYE RESEARCH, 2001, 73 (02) : 247 - 255
  • [43] Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
    Clark, Marcus
    Chang, Anthony
    Ko, Kichul
    Liarski, Vladimir
    Kinloch, Andrew
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [44] Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis
    Clark, Marcus R.
    Chang, Anthony
    Ko, Kichul
    Dunand, Carole J. Henry
    Henderson, Scott
    Brandt, Dan
    Kaverina, Natalya
    Liarski, Vladimir
    Wilson, Patrick C.
    Kinloch, Andrew J.
    ARTHRITIS RESEARCH & THERAPY, 2014, 16
  • [45] PLK1 as a potential therapeutic target of lupus
    Wu, Tianfu
    Li, Yaxi
    Mohan, Chandra
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [46] Podocytes and autophagy: a potential therapeutic target in lupus nephritis
    Zhou, Xu-Jie
    Klionsky, Daniel J.
    Zhang, Hong
    AUTOPHAGY, 2019, 15 (05) : 908 - 912
  • [47] The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
    Barati, Michelle T.
    Caster, Dawn J.
    METABOLITES, 2022, 12 (02)
  • [48] Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells
    Miyake, H
    Hara, I
    Yamanaka, K
    Gohji, K
    Arakawa, S
    Kamidono, S
    BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) : 1651 - 1656
  • [49] Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line
    DelBufalo, D
    Biroccio, A
    Leonetti, C
    Zupi, G
    FASEB JOURNAL, 1997, 11 (12): : 947 - 953
  • [50] Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells
    H Miyake
    I Hara
    K Yamanaka
    K Gohji
    S Arakawa
    S Kamidono
    British Journal of Cancer, 1999, 79 : 1651 - 1656
12345